Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Identification and characterization of stromal-like cells with CD207+/low CD1a+/low phenotype derived from histiocytic lesions – a perspective in vitro model for drug testing

Fig. 4

The results of assays aimed at determining sl-pHCs viability and mitochondrial activity. The cellular health of sl-pHCs was evaluated based on Annexin-V/7AAD staining to detect apoptotic cells (a-e), and mitochondrial membrane potential status (f-j). MTS assay was performed to monitor the metabolic activity of sl-pHCs in time (k). Columns/Boxes with bars represent mean value ± SD. Statistical differences were indicated: * p-value < 0.05, ** p-value < 0.01, *** p-value < 0.001, and ****p-value < 0.0001, while the “ns” symbol refers to non-significant differences

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us